Lilly Settles Scores Of Zyprexa Suits

Law360, New York (June 12, 2007, 12:00 AM EDT) -- Eli Lilly & Co. has settled an additional 900 lawsuits surrounding its controversial anti-psychotic drug Zyprexa, a day after a judge denied the pharmaceutical giant's motion for summary judgment in three suits in the multidistrict product liability litigation.

The Indianapolis-based company revealed the settlement on Tuesday, marking the latest in a series of rapprochements reached in the thousands of cases involving Zyprexa, a medication used to treat schizophrenia and bipolar disorder.

For the past two years, Lilly has been under attack over the drug and its...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.